Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025 GlobeNewswire - Mon Jun 16, 7:00AM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Jun 10, 3:29PM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025 GlobeNewswire - Fri May 23, 7:00AM CDT

CRNX : 30.94 (+3.44%)
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025 GlobeNewswire - Thu May 15, 3:05PM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon May 12, 3:05PM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire - Thu May 8, 3:05PM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025 GlobeNewswire - Fri Apr 11, 7:00AM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Thu Apr 10, 4:04PM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly GlobeNewswire - Thu Mar 27, 3:05PM CDT

CRNX : 30.94 (+3.44%)
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Mon Mar 10, 3:36PM CDT

CRNX : 30.94 (+3.44%)

Barchart Exclusives

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here? Barchart - Tue Jun 24, 3:43PM CDT
Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for the second half of 2025 as well. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot